Volume 29, Number 6—June 2023
Research Letter
Enhanced Adenovirus Vaccine Safety Surveillance in Military Setting, United States
John Iskander
, Scott Blanchet, Caitlin Springer, Patrick Rockwell, Dana Thomas, and Satish Pillai
, Scott Blanchet, Caitlin Springer, Patrick Rockwell, Dana Thomas, and Satish Pillai
Table
Percentages of first-year US Coast Guard cadets reporting signs or symptoms within 10 days after adenovirus vaccination in study of enhanced adenovirus vaccine safety surveillance in military setting, United States*
| Signs or symptoms | % Total† |
|---|---|
| Cough | 20.1 |
| Sore throat | 17.0 |
| Headache | 16.0 |
| Fatigue | 16.0 |
| Nasal congestion or rhinorrhea | 15.3 |
| Shortness of breath | 11.6 |
| Arthralgias or myalgias | 10.5 |
| Nausea | 8.5 |
| Fever, subjective or measured at >38.0°C | 7.8 |
| Increasing weakness in arms or legs | 5.8 |
| Numbness or tingling in hands or feet | 4.8 |
| Vomiting | 4.1 |
| Diarrhea | 3.7 |
| Abdominal pain | 2.4 |
| New rash | 0.7 |
| Dysuria | 0.0 |
| Hematuria | 0.0 |
*Total number of vaccinated cadets was 294. †Percentages sum to >100% because vaccine recipients reported multiple signs or symptoms.
Page created: April 19, 2023
Page updated: May 18, 2023
Page reviewed: May 18, 2023
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.